ciprofloxacin has been researched along with Heart Failure in 6 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " She presented to clinic with nausea and anorexia within a few days of addition of ciprofloxacin to her current regimen of medications, which included digoxin." | 3.79 | Possible digoxin toxicity associated with concomitant ciprofloxacin therapy. ( Kim, JJ; Moffett, BS; Valdes, SO, 2013) |
| "We describe a 66-year-old woman with infective endocarditis due to Cardiobacterium hominis whose condition, complicated by severe aortic regurgitation and congestive heart failure, necessitated aortic valve replacement despite treatment with ceftriaxone followed by ciprofloxacin." | 3.70 | Infective endocarditis complicated with progressive heart failure due to beta-lactamase-producing Cardiobacterium hominis. ( Hsueh, PR; Hung, CC; Jang, TN; Lu, PL; Luh, KT; Teng, LJ, 2000) |
| " The interactions between antibiotic treatment and cyclosporine therapy should be observed closely in organ transplant recipients, requiring frequent level determinations and dosing changes." | 1.33 | Successful management of two heart transplant recipients with mycobacterial pulmonary infections. ( Barten, M; Bittner, HB; Bossert, T; Gummert, JF; Mohr, FW; Rahmel, A; Richter, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, L | 1 |
| Bartash, R | 1 |
| Minamoto, GY | 1 |
| Cowman, K | 1 |
| Patel, S | 1 |
| Vukelic, S | 1 |
| Nnani, DU | 1 |
| Fauvel, D | 1 |
| Guo, Y | 1 |
| Radcliffe, C | 1 |
| Doilicho, N | 1 |
| Grant, M | 1 |
| Moffett, BS | 1 |
| Valdes, SO | 1 |
| Kim, JJ | 1 |
| Fujino, T | 1 |
| Higo, T | 1 |
| Tanoue, Y | 1 |
| Ide, T | 1 |
| Bossert, T | 1 |
| Bittner, HB | 1 |
| Richter, M | 1 |
| Rahmel, A | 1 |
| Barten, M | 1 |
| Gummert, JF | 1 |
| Mohr, FW | 1 |
| Lu, PL | 1 |
| Hsueh, PR | 1 |
| Hung, CC | 1 |
| Teng, LJ | 1 |
| Jang, TN | 1 |
| Luh, KT | 1 |
1 review available for ciprofloxacin and Heart Failure
| Article | Year |
|---|---|
Nontuberculous mycobacterial infections in left ventricular assist device patients.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Device Removal; Fatal Outcome; Heart Failu | 2020 |
5 other studies available for ciprofloxacin and Heart Failure
| Article | Year |
|---|---|
Impact of narrowing perioperative antibiotic prophylaxis for left ventricular assist device implantation.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Ciprofloxacin; Fluconazole; Heart Failure; | 2022 |
Possible digoxin toxicity associated with concomitant ciprofloxacin therapy.
Topics: Adult; Anorexia; Anti-Bacterial Agents; Cardiotonic Agents; Ciprofloxacin; Digoxin; Drug Interaction | 2013 |
FDG-PET/CT for driveline infection in a patient with implantable left ventricular assist device.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Defibrillators, Implantable; Fluorodeoxyglucose F18; He | 2016 |
Successful management of two heart transplant recipients with mycobacterial pulmonary infections.
Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Heart Failure; Heart Tr | 2005 |
Infective endocarditis complicated with progressive heart failure due to beta-lactamase-producing Cardiobacterium hominis.
Topics: Aged; Aortic Valve; Aortic Valve Insufficiency; beta-Lactamases; Ceftriaxone; Ciprofloxacin; Endocar | 2000 |